SCPH
Price
$4.37
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
8 days until earnings call
TRVI
Price
$3.18
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
9 days until earnings call
Ad is loading...

SCPH vs TRVI

Header iconSCPH vs TRVI Comparison
Open Charts SCPH vs TRVIBanner chart's image
scPharmaceuticals
Price$4.37
Change-$0.00 (-0.00%)
Volume$193.86K
CapitalizationN/A
Trevi Therapeutics
Price$3.18
Change-$0.00 (-0.00%)
Volume$419.86K
CapitalizationN/A
View a ticker or compare two or three
SCPH vs TRVI Comparison Chart
Loading...
SCPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
SCPH vs. TRVI commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCPH is a Buy and TRVI is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (SCPH: $4.37 vs. TRVI: $3.18)
Brand notoriety: SCPH and TRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SCPH: 70% vs. TRVI: 97%
Market capitalization -- SCPH: $228.63M vs. TRVI: $242.46M
SCPH [@Biotechnology] is valued at $228.63M. TRVI’s [@Biotechnology] market capitalization is $242.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SCPH’s FA Score shows that 0 FA rating(s) are green whileTRVI’s FA Score has 0 green FA rating(s).

  • SCPH’s FA Score: 0 green, 5 red.
  • TRVI’s FA Score: 0 green, 5 red.
According to our system of comparison, TRVI is a better buy in the long-term than SCPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SCPH’s TA Score shows that 5 TA indicator(s) are bullish while TRVI’s TA Score has 3 bullish TA indicator(s).

  • SCPH’s TA Score: 5 bullish, 5 bearish.
  • TRVI’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, SCPH is a better buy in the short-term than TRVI.

Price Growth

SCPH (@Biotechnology) experienced а -1.13% price change this week, while TRVI (@Biotechnology) price change was -5.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

SCPH is expected to report earnings on Mar 19, 2025.

TRVI is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRVI($242M) has a higher market cap than SCPH($229M). TRVI YTD gains are higher at: 137.313 vs. SCPH (-30.303). TRVI has higher annual earnings (EBITDA): -38.63M vs. SCPH (-51.74M). TRVI has more cash in the bank: 69.5M vs. SCPH (38.5M). TRVI has less debt than SCPH: TRVI (1.19M) vs SCPH (41.4M). SCPH has higher revenues than TRVI: SCPH (24M) vs TRVI (0).
SCPHTRVISCPH / TRVI
Capitalization229M242M95%
EBITDA-51.74M-38.63M134%
Gain YTD-30.303137.313-22%
P/E RatioN/AN/A-
Revenue24M0-
Total Cash38.5M69.5M55%
Total Debt41.4M1.19M3,470%
FUNDAMENTALS RATINGS
SCPH: Fundamental Ratings
SCPH
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SCPHTRVI
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
SCPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

SCPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPH has been loosely correlated with XERS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPH jumps, then XERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPH
1D Price
Change %
SCPH100%
+4.05%
XERS - SCPH
45%
Loosely correlated
+0.94%
INZY - SCPH
43%
Loosely correlated
-0.21%
BEAM - SCPH
43%
Loosely correlated
+3.71%
AVIR - SCPH
42%
Loosely correlated
+2.39%
MGTX - SCPH
42%
Loosely correlated
+0.34%
More

TRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRVI has been loosely correlated with ATNM. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if TRVI jumps, then ATNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRVI
1D Price
Change %
TRVI100%
+1.92%
ATNM - TRVI
35%
Loosely correlated
+8.93%
GBIO - TRVI
34%
Loosely correlated
+9.35%
SCPH - TRVI
34%
Loosely correlated
+4.05%
CMPX - TRVI
34%
Loosely correlated
-2.91%
KRYS - TRVI
33%
Loosely correlated
+0.79%
More